Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

• Published in: Journal of headache and pain Vol. 20; no. 1; pp. 84 - 11
• Main Authors: Loo, Li Shen, Ailani, Jessica, Schim, Jack, Baygani, Simin, Hundemer, Hans-Peter, Port, Martha, Krege, John H.
• Format: Journal Article
• Language: English
• Published: Milan Springer Milan 24.07.2019; Springer Nature B.V; BMC
• Subjects: Acute treatment; Botulinum toxin; Botulinum toxin type A; Clinical trials; Concomitant; Ditan; Efficacy; Evidence-based medicine; Headache; Internal Medicine; Lasmiditan; Medicine; Medicine & Public Health; Migraine; Neurology; Pain; Pain Medicine; Research Article; Safety; Acute treatment; Ditan; Migraine medication; Migraine; Efficacy; Lasmiditan; Concomitant; Migraine prophylaxis; Migraine preventive

Objective To study the efficacy and safety of lasmiditan for acute treatment of migraine in patients using migraine preventive medications. Background While lasmiditan has been proven to be an effective acute treatment for migraine, its effectiveness has not been examined when used concurrently with...